Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Alexander MartensBenjamin Weide

Abstract

To identify baseline peripheral blood biomarkers associated with clinical outcome following ipilimumab treatment in advanced melanoma patients. Frequencies of myeloid-derived suppressor cells (MDSC) and regulatory T cells (Treg), serum lactate dehydrogenase (LDH), routine blood counts, and clinical characteristics were assessed in 209 patients. Endpoints were overall survival (OS) and best overall response. Statistical calculations were done by Kaplan-Meier and Cox regression analysis, including calibration and discrimination by C-statistics. Low baseline LDH, absolute monocyte counts (AMC), Lin(-)CD14(+)HLA-DR(-/low)-MDSC frequencies, and high absolute eosinophil counts (AEC), relative lymphocyte counts (RLC), and CD4(+)CD25(+)FoxP3(+)-Treg frequencies were significantly associated with better survival, and were considered in a combination model. Patients (43.5%) presenting with the best biomarker signature had a 30% response rate and median survival of 16 months. In contrast, patients with the worst biomarkers (27.5%) had only a 3% response rate and median survival of 4 months. The occurrence of adverse events correlated with neither baseline biomarker signatures nor the clinical benefit of ipilimumab. In another model, limit...Continue Reading

References

Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert L CampDavid L Rimm
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter AttiaSteven A Rosenberg
Mar 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ljubov SimsonChristopher R Parish
Nov 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephanie G DowneySteven A Rosenberg
Feb 7, 2009·Nature Reviews. Immunology·Dmitry I Gabrilovich, Srinivas Nagaraj
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Sep 22, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jianda YuanSacha Gnjatic
Mar 23, 2012·Nature Reviews. Immunology·Dmitry I GabrilovichVincenzo Bronte
Apr 24, 2012·Journal of Immunological Methods·Athanasios KotsakisTheresa L Whiteside
Apr 25, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin WeideGraham Pawelec
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Jul 4, 2012·Oncoimmunology·Pia KvistborgTon N M Schumacher
Jul 14, 2012·Journal of Translational Medicine·Wenshi WangJeffrey S Weber
Feb 5, 2013·Nature·Heidi BraumüllerMartin Röcken
Mar 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paolo A AsciertoJedd D Wolchok
Sep 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nienke van RooijTon N Schumacher
Dec 11, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin WeideGraham Pawelec
Dec 21, 2013·Cancer Immunology, Immunotherapy : CII·Christiane MeyerDaniel E Speiser
Mar 13, 2014·Cancer Immunology, Immunotherapy : CII·Sander KeldermanChristian U Blank
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertDirk Schadendorf
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dirk SchadendorfJedd D Wolchok
Aug 1, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S ValpioneV Chiarion-Sileni
Aug 21, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christoffer GebhardtViktor Umansky
Nov 26, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stefan DiemJames Larkin

❮ Previous
Next ❯

Citations

Apr 29, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G MansonR Houot
May 30, 2016·Cellular and Molecular Life Sciences : CMLS·Christopher ShippGraham Pawelec
May 31, 2016·Current Opinion in Immunology·Jennifer A WargoPadmanee Sharma
Jul 12, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Kilian Wistuba-HamprechtBenjamin Weide
Jun 23, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A HeineP Brossart
Jul 29, 2016·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·Klaus G Griewank
Jul 13, 2016·Expert Review of Anticancer Therapy·Pol Specenier
Aug 4, 2016·Endocrine-related Cancer·S LatteyerD Führer
Aug 25, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·P ArenbergerM Arenbergerova
Oct 12, 2016·International Immunopharmacology·Joana FelixHélène Moins-Teisserenc
Nov 10, 2016·Vaccines·Viktor UmanskyJochen Utikal
Nov 26, 2016·International Journal of Molecular Sciences·Gabor J SzebeniLaszlo G Puskas
Apr 12, 2017·Journal of Chemotherapy·Alberto RussiAngelo Claudio Palozzo
Apr 20, 2017·JCI Insight·Stefanie GrossBeatrice Schuler-Thurner
Jun 28, 2017·Nature Reviews. Clinical Oncology·Mizuki NishinoF Stephen Hodi
Jun 27, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Markus V HepptCarola Berking
Jul 26, 2017·Nature Reviews. Clinical Oncology·Wolf H FridmanGuido Kroemer
Jan 9, 2018·Oncoimmunology·Gilda VarricchiGiovanna Schiavoni
Mar 8, 2018·Journal for Immunotherapy of Cancer·Priyanka B SubrahmanyamF Stephen Hodi
Apr 11, 2018·Immunology and Cell Biology·Salman M Toor, Eyad Elkord
Feb 8, 2018·Molecular Diagnosis & Therapy·Anna EisensteinRhoda M Alani
Sep 28, 2017·Cancer Immunology, Immunotherapy : CII·Liam Friel TrembleDeclan M Soden
Dec 18, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kilian Wistuba-HamprechtGraham Pawelec
Oct 13, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·T GambichlerL Susok
Nov 18, 2017·Journal of Translational Medicine·Paolo A AsciertoMagdalena Thurin
Sep 8, 2017·Immunotherapy·Hiromasa KurodaTadashi Kimura
Nov 15, 2017·Future Oncology·Zineb HamilouYohann Loriot
Jun 22, 2018·Critical Reviews in Clinical Laboratory Sciences·Karolina OklaJan Kotarski
Aug 4, 2018·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Seiji MabuchiTadashi Kimura
Sep 8, 2018·The Journal of Pathology. Clinical Research·Marieke E IjsselsteijnNoel Fcc de Miranda
Dec 21, 2018·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Valerie K ConradWilliam L Redmond
Nov 22, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M OlivaL L Siu
Jan 19, 2018·Molecular Cancer·Su Yin LimHelen Rizos
Jan 5, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K M HeinhuisJ H M Schellens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.